161 related articles for article (PubMed ID: 19345321)
1. Unraveling the complexities of androgen receptor signaling in prostate cancer cells.
Heemers HV; Tindall DJ
Cancer Cell; 2009 Apr; 15(4):245-7. PubMed ID: 19345321
[TBL] [Abstract][Full Text] [Related]
2. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
4. Nur77 suppression facilitates androgen deprivation-induced cell invasion of prostate cancer cells mediated by TGF-β signaling.
Wu J; Sun H; Yang X; Sun X
Clin Transl Oncol; 2018 Oct; 20(10):1302-1313. PubMed ID: 29594945
[TBL] [Abstract][Full Text] [Related]
5. BAG1L: a promising therapeutic target for androgen receptor-dependent prostate cancer.
Lee II; Kuznik NC; Rottenberg JT; Brown M; Cato ACB
J Mol Endocrinol; 2019 May; 62(4):R289-R299. PubMed ID: 30913537
[TBL] [Abstract][Full Text] [Related]
6. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
[TBL] [Abstract][Full Text] [Related]
7. AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.
Li P; Lee H; Guo S; Unterman TG; Jenster G; Bai W
Mol Cell Biol; 2003 Jan; 23(1):104-18. PubMed ID: 12482965
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer: Re-focusing on androgen receptor signaling.
Nieto M; Finn S; Loda M; Hahn WC
Int J Biochem Cell Biol; 2007; 39(9):1562-8. PubMed ID: 17321194
[TBL] [Abstract][Full Text] [Related]
9. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression.
Schaefer-Klein JL; Murphy SJ; Johnson SH; Vasmatzis G; Kovtun IV
PLoS One; 2015; 10(11):e0142327. PubMed ID: 26560244
[TBL] [Abstract][Full Text] [Related]
11. Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation.
Brown NE; Paluch AM; Nashu MA; Komurov K; Waltz SE
Neoplasia; 2018 Sep; 20(9):917-929. PubMed ID: 30121008
[TBL] [Abstract][Full Text] [Related]
12. Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.
Zou JX; Guo L; Revenko AS; Tepper CG; Gemo AT; Kung HJ; Chen HW
Cancer Res; 2009 Apr; 69(8):3339-46. PubMed ID: 19318566
[TBL] [Abstract][Full Text] [Related]
13. The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways.
Edwards J; Bartlett JM
BJU Int; 2005 Jun; 95(9):1327-35. PubMed ID: 15892826
[No Abstract] [Full Text] [Related]
14. Mechanistic concepts in androgen-dependence of prostate cancer.
Craft N; Sawyers CL
Cancer Metastasis Rev; 1998-1999; 17(4):421-7. PubMed ID: 10453286
[TBL] [Abstract][Full Text] [Related]
15. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells.
Church DR; Lee E; Thompson TA; Basu HS; Ripple MO; Ariazi EA; Wilding G
Prostate; 2005 May; 63(2):155-68. PubMed ID: 15486991
[TBL] [Abstract][Full Text] [Related]
16. Genomic analysis of DNA repair genes and androgen signaling in prostate cancer.
Jividen K; Kedzierska KZ; Yang CS; Szlachta K; Ratan A; Paschal BM
BMC Cancer; 2018 Oct; 18(1):960. PubMed ID: 30305041
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.
Chen M; Feuerstein MA; Levina E; Baghel PS; Carkner RD; Tanner MJ; Shtutman M; Vacherot F; Terry S; de la Taille A; Buttyan R
Mol Cancer; 2010 Apr; 9():89. PubMed ID: 20420697
[TBL] [Abstract][Full Text] [Related]
18. Interactions between vitamin D and androgen receptor signaling in prostate cancer cells.
Weigel NL
Nutr Rev; 2007 Aug; 65(8 Pt 2):S116-7. PubMed ID: 17867385
[No Abstract] [Full Text] [Related]
19. The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin.
Chen ST; Okada M; Nakato R; Izumi K; Bando M; Shirahige K
J Biol Chem; 2015 Aug; 290(35):21713-23. PubMed ID: 26175158
[TBL] [Abstract][Full Text] [Related]
20. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]